Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 22, Pages 8627
Publisher
MDPI AG
Online
2020-11-17
DOI
10.3390/ijms21228627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination therapy with oncolytic viruses and immune checkpoint inhibitors
- (2020) Matthew Chiu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Repurposing infectious disease vaccines for intratumoral immunotherapy
- (2020) Ignacio Melero et al. Journal for ImmunoTherapy of Cancer
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Oncolytic viruses for cancer immunotherapy
- (2020) Otto Hemminki et al. Journal of Hematology & Oncology
- Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
- (2020) Luana Guerra et al. Cell Reports
- Genomic correlates of response to immune checkpoint blockade
- (2019) Tanya E. Keenan et al. NATURE MEDICINE
- Immunological impact of canerpaturev (C-REV, formerly HF10), an oncolytic viral immunotherapy, with or without ipilimumab (Ipi) for advanced solid tumor patients (pts).
- (2019) Takayuki Nakayama et al. JOURNAL OF CLINICAL ONCOLOGY
- Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
- (2019) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells
- (2019) Biswajit Das et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- (2019) Venkatesh Sivanandam et al. Molecular Therapy-Oncolytics
- Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
- (2019) Robert H. I. Andtbacka et al. Journal for ImmunoTherapy of Cancer
- Immuno-oncology drug development goes global
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
- (2019) Devalingam Mahalingam et al. CLINICAL CANCER RESEARCH
- Toxicities associated with checkpoint inhibitors—an overview
- (2019) Laura Spiers et al. RHEUMATOLOGY
- Recombinant Poliovirus for Cancer Immunotherapy
- (2018) Matthias Gromeier et al. Annual Review of Medicine
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- The Development of Oncoltyic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer
- (2018) Mizuho Sato-Dahlman et al. CURRENT CANCER DRUG TARGETS
- Emergence of Ad-Mediated Combination Therapy Against Cancer: What to Expect?
- (2018) JinWoo Hong et al. CURRENT CANCER DRUG TARGETS
- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients
- (2018) Yasuhiro Fujisawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
- (2018) Nikolas Tim Martin et al. MOLECULAR THERAPY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
- (2018) Marie-Claude Bourgeois-Daigneault et al. Science Translational Medicine
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer
- (2018) Matthew J. Atherton et al. VACCINE
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- The advent of oncolytic virotherapy in oncology: The Rigvir® story
- (2018) Pēteris Alberts et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Single intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumor immunity.
- (2018) Alan Anthoney et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant oncolytic poliovirus combined with checkpoint blockade for breast cancer therapy.
- (2018) Jeremy Force et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
- (2018) Jonathan G. Pol et al. OncoImmunology
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
- (2018) Jonathan G. Pol et al. OncoImmunology
- Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune checkpoint blockade
- (2018) Hong Jae Chon et al. CLINICAL CANCER RESEARCH
- Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
- (2018) Frank Stephen Hodi et al. LANCET ONCOLOGY
- ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)
- (2018) Gelareh Zadeh et al. NEURO-ONCOLOGY
- Second- and third-generation drugs for immuno-oncology treatment—The more the better?
- (2017) Wolfram C.M. Dempke et al. EUROPEAN JOURNAL OF CANCER
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
- (2017) Dmitriy Zamarin et al. Nature Communications
- Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
- (2017) Zuqiang Liu et al. Nature Communications
- TILT Biotherapeutics
- (2017) Akseli Hemminki Human Vaccines & Immunotherapeutics
- Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV
- (2017) Lauro Velazquez-Salinas et al. Human Gene Therapy Clinical Development
- Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
- (2017) Sam Illingworth et al. Molecular Therapy-Oncolytics
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
- (2017) Ibrahim Ragab Eissa et al. Frontiers in Oncology
- Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery
- (2017) Dana Haddad Frontiers in Oncology
- Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes
- (2017) Nalini Marino et al. PLoS One
- The MITCI (phase 1b) study: a novel immunotherapy combination of coxsackievirus A21 and ipilimumab in patients with advanced melanoma
- (2016) B. Curti et al. ANNALS OF ONCOLOGY
- Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
- (2016) Adel Samson et al. GUT
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Erratum: Oncolytic viruses: a new class of immunotherapy drugs
- (2016) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Tremelimumab: research and clinical development
- (2016) Francisco Javier Ibarrondo et al. OncoTargets and Therapy
- Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model
- (2016) Eonju Oh et al. Oncotarget
- Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer
- (2016) Gulidanna Shayan et al. OncoImmunology
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses: Therapeutics With an Identity Crisis
- (2016) Caroline J. Breitbach et al. EBioMedicine
- Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus
- (2015) Chang Yoon Moon et al. BIOMATERIALS
- Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
- (2015) W. Shen et al. BLOOD
- Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
- (2015) F. J. Kohlhapp et al. CLINICAL CANCER RESEARCH
- Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
- (2015) Volker Schirrmacher EXPERT OPINION ON BIOLOGICAL THERAPY
- Vaccinia virus, a promising new therapeutic agent for pancreatic cancer
- (2015) Chadwan Al Yaghchi et al. Immunotherapy
- The oncolytic virus, pelareorep, as a novel anticancer agent: a review
- (2015) Romit Chakrabarty et al. INVESTIGATIONAL NEW DRUGS
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic
- (2015) Caroline J Breitbach et al. Current Opinion in Virology
- Oncolytic viruses: From bench to bedside with a focus on safety
- (2015) Pascal RA Buijs et al. Human Vaccines & Immunotherapeutics
- Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
- (2015) L Vassilev et al. OncoImmunology
- Abstract 2939: CAVATAK-mediated oncolytic immunotherapy in advanced melanoma patients
- (2015) Robert H. Andtbacka et al. CANCER RESEARCH
- Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers
- (2014) T Du et al. CANCER GENE THERAPY
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Utilizing adenovirus vectors for gene delivery in cancer
- (2014) Dayananda Kasala et al. Expert Opinion on Drug Delivery
- Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood
- (2014) Y Di et al. GENE THERAPY
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease
- (2014) Jiqing Zhang et al. MOLECULAR THERAPY
- Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+T-cell response, prominent infiltration of CD8+lymphocytes and Th1 type polarization
- (2014) Tuuli Ranki et al. OncoImmunology
- Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
- (2014) Andrew Nguyen et al. Frontiers in Oncology
- Activated Ras Signaling Pathways and Reovirus Oncolysis: An Update on the Mechanism of Preferential Reovirus Replication in Cancer Cells
- (2014) Jun Gong et al. Frontiers in Oncology
- Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms
- (2013) S A Gujar et al. BRITISH JOURNAL OF CANCER
- Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers
- (2013) I-K Choi et al. CANCER GENE THERAPY
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Exposure-Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma
- (2013) Y. Feng et al. CLINICAL CANCER RESEARCH
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncolytic Vesicular Stomatitis Virus in an Immunocompetent Model of MUC1-Positive or MUC1-Null Pancreatic Ductal Adenocarcinoma
- (2013) E. Hastie et al. JOURNAL OF VIROLOGY
- Oncolytic virus therapy for cancer: the first wave of translational clinical trials
- (2013) Manish R. Patel et al. Translational Research
- Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy
- (2013) D. Ng Tang et al. Cancer Immunology Research
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β
- (2012) S Naik et al. CANCER GENE THERAPY
- Clinical Development of Oncolytic Viruses in China
- (2012) Min Liang CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets
- (2012) Gunnel Halldén et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Curative one-shot systemic virotherapy in murine myeloma
- (2012) S Naik et al. LEUKEMIA
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Vesicular stomatitis virus as a treatment for colorectal cancer
- (2011) J H Stewart et al. CANCER GENE THERAPY
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4
- (2011) J D Dias et al. GENE THERAPY
- Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD
- (2011) J J Rojas et al. GENE THERAPY
- Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
- (2011) Gough G Au et al. Virology Journal
- A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer
- (2010) M. P. Lolkema et al. CLINICAL CANCER RESEARCH
- Oncolytic virotherapy of gynecologic malignancies
- (2010) Andreas D. Hartkopf et al. GYNECOLOGIC ONCOLOGY
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus
- (2010) Jan Brun et al. MOLECULAR THERAPY
- Gene medicine for cancer treatment: Commercially available medicine and accumulated clinical data in China
- (2010) Masatoshi Tagawa Drug Design Development and Therapy
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination
- (2009) M Takakura et al. CANCER GENE THERAPY
- Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
- (2009) G. Wollmann et al. JOURNAL OF VIROLOGY
- Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
- (2009) Jing-Hua Huang et al. MOLECULAR THERAPY
- Oncolytic virotherapy for multiple myeloma
- (2008) Amaalia E Stief et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
- (2008) Lan Wu et al. HUMAN GENE THERAPY
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search